|Base Year Market Size
|USD 617.29 Million
|Forecast Year Market Size
|USD 856.05 Million
|Fastest Growing Market
The global elastomer infusion pump market size was valued at USD 617.29 million in 2022. It is estimated to reach USD 856.05 million by 2031, growing at a CAGR of 3.7% during the forecast period (2023–2031). The rising burden on hospitals to reduce healthcare costs globally and the development of novel elastomeric infusion pumps will drive the demand for elastomer infusion pumps.
Elastomeric infusion pumps are non-electric, disposable pumps that deliver fluids, such as antibiotics, analgesics, and chemotherapy drugs, into a patient's body in controlled amounts. The elastomeric infusion pump consists of the elastomeric layer, which provides the required pressure for administrating the drug. These pumps provide advanced benefits over conventional infusion pumps in portability, feasibility, and less scope for human errors. In addition, these pumps do not require electricity or the action of gravity. Moreover, it can be used for a variable period ranging from a few minutes to several days. There are two types of elastomer infusion pumps, which include continuous rate pumps and variable rate pumps.
The rising burden on hospitals due to increased hospital admissions has posed an important concern for healthcare facilities globally. Hospitals are facing the burden of healthcare costs due to an increase in the prevalence of chronic diseases and several surgical procedures. Domestic government authorities are stressing decreasing hospital admissions by promising treatments in outpatient settings and offering home care solutions. Considering the same, growth in government initiatives to promote home medication, awareness about efficient use of elastomer infusion in home care settings, and improved design of infusion pumps, making them easier and safer to use at home, further drives this market. Thus, a rising burden on hospitals to reduce healthcare costs globally will boost the demand for elastomer infusion pumps.
Elastomeric infusion pumps in the pain management, infection management, and chemotherapy market are observed to be highly competitive and comprise a large number of players. However, the market is currently dominated by a few players, such as B Braun Melsungen Ag, Baxter International Inc., and Promecon GmbH. The development of novel elastomer infusion pumps offers advanced features compared to conventional electronic pumps, such as portable, feasible, and low-cost devices, which drives the adoption of elastomer infusion pumps in the market. In addition, factors such as increased comfort, high patient satisfaction, and dose customization are expected to influence further the growth of novel elastomeric infusion pumps in the market. Thus, the development of novel elastomeric infusion pumps will drive the demand for elastomer infusion pumps.
Lack of financial resources, poor income, fewer pharmaceutical companies, and lack of advanced manufacturing systems hamper the growth of the elastomer infusion pump market in under-developed countries in Asia and Africa. Furthermore, inadequate support by government agencies for adopting elastomer infusion pump products and a lack of trained professionals impede the growth of the elastomer infusion pump market in underdeveloped countries such as Ethiopia, Afghanistan, and Guinea.
Opportunities in untapped, emerging markets will likely drive the growth of the elastomer infusion pump market due to improved medical device industry infrastructure, a rise in medical device industries, and an increase in demand for elastomer infusion pump products. The healthcare industry in emerging economies is developing significantly due to increased demand for better-advanced manufacturing systems and significant government investments to improve healthcare infrastructure. Moreover, emerging markets, such as China and India, are hubs of medical device companies, which will further contribute to the growth of this market.
Based on region, the global elastomer infusion pump market is bifurcated into North America, Europe, Asia-Pacific, and LAMEA.
North America is the most significant global elastomer infusion pump market shareholder and is estimated to grow at a CAGR of 2.7% over the forecast period. This is majorly attributed to the development of technologically advanced elastomer infusion pump products, increased adoption of elastomer infusion pump products, and rise in non-government and government initiatives to promote healthcare.The presence of major key players in the region, such as Baxter International Inc., Halyard Health, Nipro Medical Corporation, Pfizer Inc., and others, is a major factor contributing to the growth of the elastomer infusion pump market. In addition, the rise in demand for elastomer infusion pumps, the presence of advanced healthcare facilities with trained medical professionals, and a surge in the number of R and D centers thereby contributed toward the growth of the North American market.
Europe will likely exhibit a CAGR of 3.7% over the forecast period. A high population base, a surge in disposable income, and an increase in demand for emerging technologies boost the growth of the European elastomer infusion pump market. Moreover, hospitals in Europe are increasingly investing in elastomer infusion pump products due to a surge in demand for elastomer infusion pumps for post-operative pain management. The market for elastomer infusion pumps in Germany, France, and the UK is anticipated to show significant growth, owing to the strong presence of key players, availability of developed healthcare infrastructure, and technological innovations, which influence the market growth in Europe.
In Asia-Pacific, the market growth is attributable to its high population base, increased prevalence of chronic diseases in various countries, and surge in demand for elastomer infusion pump products. In addition, the rise in the number of small and mid-sized hospitals and the increase in the number of key players and startup firms are other factors contributing to the growth of this market. Owing to improvement in healthcare infrastructure, the developing R&D sector, surge in healthcare reforms, and technological advancements in the healthcare field. In addition, the rise in the focus of leading manufacturers on expanding their geographic presence in the emerging Asia-Pacific countries to capture high growth opportunities is anticipated to augment the market's growth. Moreover, China is anticipated to grow at the fastest CAGR during the forecast period, owing to the presence of the highest population, a significant surge in demand for advanced medical facilities, and a rise in R&D activities in the medical device sector in the region.
In LAMEA, the elastomer infusion pump market is nascent due to the lack of medical device companies with advanced manufacturing facilities and trained professionals. LAMEA is an emerging market and is expected to provide lucrative growth opportunities for the key players, owing to an increase in the target population, the surge in demand for elastomer infusion pumps, and improvement in healthcare infrastructure. Moreover, the increase in the prevalence of chronic diseases in LAMEA has fueled the adoption of elastomer infusion pumps, thereby driving market growth.
|B Braun Melsungen Ag Baxter International Inc. Heka Healthcare Nipro Medical Corporation (Nipro Medical Europe NV) Pfizer Inc. (Hospira Inc.) Promecon GmbH Halyard Health Palex Medical SA Pfm Medical Ag Samtronic SA
|U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
|China Korea Japan India Australia Singapore Taiwan South East Asia Rest of Asia-Pacific
|Middle East and Africa
|UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
|Brazil Mexico Argentina Chile Colombia Rest of LATAM
|Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global elastomer infusion pump market is bifurcated into products, applications, and end-users.
Based on the product, the global elastomer infusion pump market is bifurcated into continuous and variable-rate pumps.
The continuous rate pumps segment dominates the global market and will likely exhibit a CAGR of 3.3% over the forecast period. A continuous-rate elastomeric pump is mainly used for intra-arterial, epidural, or subcutaneous infusion. A continuous rate elastomeric pump delivers a constant amount of drug per unit of time, especially when short-acting drugs are desired for long periods or when consistent plasma concentrations of drugs are desirable. These pumps are commonly used for anesthesia and analgesia but are also useful in administering some antibiotics, antiemetics, and anticonvulsants.
Drugs with short duration of action technically facilitate rapid and accurate titration of doses to meet the individual patient requirement. Three types of continuous rate pumps are pain management, antiviral/antibiotic, and chemotherapy. The rise in demand for continuous-rate elastomeric pumps, wide usage of continuous-rate pumps in chronic disease treatment, increase in adoption of elastomer infusion pumps for postoperative pain management, and increase in application in cancer treatment across the globe influence the market growth of this segment. Some of the continuous rate pumps available in the market include the On-Q pump fixed flow marketed by Avanos Medical, Inc., and EPIC–SMARTeZ disposable elastomeric pumps marketed by Progressive Medical, Inc.
Based on application, the elastomer infusion pump market is bifurcated into pain management, infection management, chemotherapy, and others.
The pain management segment owns the global market and is predicted to exhibit a CAGR of 2.7% over the forecast period. Elastomer infusion pumps are single-use pumps that permit safe, continuous drug infusion. These pumps administer anesthetic and painkiller drugs to treat lesions or inflamed tissue. In addition, pain management using an elastomer infusion pump helps to maintain analgesia and drug plasma level stability to control acute pain and improve the patient's quality of life. Moreover, elastomer infusion pumps act as superior analgesic devices and fewer complications are observed as compared to opioid dosage treatment. Some of the elastomer infusion pumps for pain management that are available in the market include the MYFUSER elastomeric pump, marketed by Palex Medical, and the Neofuser portable elastomeric infusion pump, marketed by Smiths Medical, Inc.
The global elastomer infusion pump market is segmented based on end-users into hospitals and clinics, ambulatory care, and home care.
The home care segment dominates the global market and is predicted to exhibit a CAGR of 5.94% during the forecast period. Home care is a healthcare service provided by skilled medical practitioners to patients in their homes under the direction of a physician. Home care services include nursing care, speech-language therapy, and medical social services. Moreover, it helps individuals administer drugs to patients suffering from chronic diseases using an elastomer infusion pump. Better reimbursement policies and a rise in preference for home care for chronic disease management to save treatment costs have boosted the growth of the home care segment.